# Kaken Pharmaceutical Co., Ltd. – FDA Inspection, Jun 22, 2018

Source: https://www.keypedia.com/records/fda_inspections/kaken-pharmaceutical-co-ltd/15291c56-7260-4bae-96a7-86f32476adaa
Source feed: FDA_Inspections

> FDA inspection 1056547 of Kaken Pharmaceutical Co., Ltd., June 22, 2018. Classification: Voluntary Action Indicated (VAI). 9 citations under 21 CFR part 211. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1056547
- Company Name: Kaken Pharmaceutical Co., Ltd.
- Inspection Date: 2018-06-22
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 9

## Related Documents

- FDA Inspection 1219421 - 2023-09-01
- FDA Inspection 873743 - 2014-03-28
- [FDA Inspection 813922 - 2012-11-14](https://www.keypedia.com/records/fda_inspections/kaken-pharmaceutical-co-ltd/de103411-2cb7-4314-b542-04b7f79e8621)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/yasamin-ameri/73021772-c960-4c65-aa30-cb490866ee58)

Company: https://www.keypedia.com/companies/kaken-pharmaceutical-co-ltd/047de00d-0f41-4808-8bcb-58970bebd083

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c